SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-254145
Filing Date
2013-06-11
Accepted
2013-06-11 08:05:24
Documents
5
Period of Report
2013-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d552330d8k.htm 8-K 34267
2 EX-10.1 d552330dex101.htm EX-10.1 87587
3 EX-99.1 d552330dex991.htm EX-99.1 9810
4 GRAPHIC g552330im1.jpg GRAPHIC 9561
5 GRAPHIC g552330im12.jpg GRAPHIC 6231
  Complete submission text file 0001193125-13-254145.txt   155316
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 13905047
SIC: 2834 Pharmaceutical Preparations